Please provide your email address to receive an email when new articles are posted on . As presbyopia-correcting drops have started to enter the marketplace, many anterior segment surgeons are talking ...

Please provide your email address to receive an email when new articles are posted on . A second dose of Vuity 3 to 6 hours after the first dose may extend the effect for up to 9 hours. The most ...

A new formulation of pilocarpine eyedrops, Allergan's AGN-190584, could take the place of reading glasses for many people with presbyopia, researchers say. A significant proportion of patients gained ...

- Presbyopia, or age-related blurry near vision, is a common, progressive condition that reduces the eye's ability to focus on near objects and affects nearly half of the U.S. adult population, ...

Approximately 128 million Americans may be able to ditch reading glasses thanks to newly approved eye drops. On December 9, pharmaceutical manufacturer Allergan unveiled its VUITY (pilocarpine HCl ...

A: Presbyopia occurs when the eyes have difficulty seeing close up. This is a normal aging process that presents gradually after age 40. The natural lens inside the eye has the ability to focus on ...

The US Food and Drug Administration for the first time has approved an eye drop to treat presbyopia, also known as age-related blurry near vision, in adults. Pilocarpine HCl ophthalmic solution 1.25% ...

The approval was based on data from the phase 3 GEMINI 1 and GEMINI 2 studies that evaluated Vuity in a total of 750 patients aged 40 to 55 years with presbyopia. The Food and Drug Administration (FDA ...

A new drug that could help more than 128 million Americans read without needing glasses has been submitted to the Food and Drug Administration for approval. The investigational eye drop – called ...

The most common symptoms of presbyopia are blurred vision of near objects and difficulty doing close work. Many people find reading difficult and hold the material farther away in an attempt to see ...